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Mucociliary clearance is determined by ciliary activity and rheology of ASL, concentration of mucin macromolecules, and slowing
of airway surface liquid. To test the hypothesis that mucociliary of MCC (7, 8). In vivo, aerosolized hypertonic saline or man-
clearance would increase after inhalation of an osmotically active nitol increases the rate of mucus clearance in patients with
agent that would increase the volume of airway surface liquid, we cystic fibrosis, perhaps reflecting partial restoration of ASL
measured mucociliary clearance in 16 normal subjects after inhala- volume (11, 12). In contrast to cystic fibrosis, patients with
tion of varying tonicities of saline alone, and after pretreatment systemic pseudohypoaldosteronism (PHA) have loss-of-func-
with a Na channel blocker (amiloride). Subjects inhaled vehicle tion mutations in the epithelial Na channel (ENaC) and
(0.12% saline) or amiloride, followed by inhalation of 0.12, 0.9, or an absence of airway epithelial Na absorption, which is
7% saline. Subsequently, mucociliary clearance rates were mea- associated with an increased volume of isotonic ASL (13,sured by  scintigraphy of inhaled 99mTc Fe2O3. Mucociliary clearance 14). Adults with PHA appear to “compensate” for the excessof whole and peripheral lung was increased (approximately two-
ASL by accelerated rates of clearance of liquid (MCC) fromfold) after inhalation of increasing concentrations of saline (p 
the airway surface (14).0.04). Pretreatment with amiloride increased mucociliary clearance
No previous study has systematically tested the relation-rates (approximately twofold) after inhalation of 0.12 and 0.9%
ship between an acute increase in ASL volume and the ratesaline (p  0.05), but not 7% saline. The rates of mucociliary clear-
of MCC in normal subjects. The goal of the current studyance by pretreatment with amiloride and 7% saline alone (approxi-
was to study the effect of maneuvers predicted to acutelymately 1.4% per minute) approached the rapid mucociliary clear-
ance rates (approximately 2.0% per minute) reported in systemic increase the volume of ASL on MCC rates in normal subjects.
pseudohypoaldosteronism, which has loss-of-function mutations of Our strategy was to measure MCC rates with isotopic mark-
the epithelial Na channel and an increased volume of airway sur- ers delivered after airway surfaces were dosed by inhalation
face liquid. We conclude that maneuvers that increase the volume with increasing amounts of NaCl in aerosolized 0.12, 0.9, and
of airway surface liquid are associated with increased rates of muco- 7% saline. We further tested the hypothesis that pretreatment
ciliary clearance in normal subjects. with inhaled amiloride, an Na channel blocker, might in-
crease the magnitude of inhaled NaCl–induced changes inKeywords: mucociliary clearance; airway surface liquid; epithelial Na
MCC by preventing Na (and ASL volume) absorption overchannel; aerosolized NaCl
the MCC measurement interval (4, 15).
Mucociliary clearance (MCC) rates depend on ciliary activity
coupled to the volume and rheological properties of airway METHODS
surface liquid (ASL) (1), and rates of MCC can be upregu-
Subjectslated for airway host defense. Under normal circumstances,
Sixteen normal subjects completed this protocol. The first cohortthere is cephalad movement of the ASL secondary to ciliary
(Group 1; Table 1) had seven subjects (six females) with a mean ageactivity (2). The volume (depth) of ASL is regulated by
of 25 years. The second cohort (Group 2) had 10 subjects (5 females)isotonic volume transport, with active Na absorption as the
with a mean age of 29.9 years; 1 subject (female, aged 22 years) wasdominant basal ion transport activity of the airway surface
excluded based on predetermined criteria because of variation in ratioepithelia (2–8). In vitro, the acute addition of NaCl expands
of central to peripheral (C/P) radionuclide counts. The study was ap-ASL height (9), improves mucus rheologic properties (elas- proved by the University of North Carolina IRB and informed consent
ticity and viscosity), and accelerates mucus transport rates was obtained.
(9, 10).
In cystic fibrosis there is accelerated absorption of NaCl Techniques
from airway surfaces, which leads to reduced volume (depth) Drug preparation, storage, and administration. Dry powder amiloride
(Merck, West Point, PA) was dissolved in 0.12% saline as a stock
(102 M).
Radioisotopic aerosol labeling, generation, and administration. The
aerosol (4 m mass median aerodynamic diameter [MMAD]) was(Received in original form April 7, 2002; accepted in final form October 21, 2002)
formed from 2% (by weight) colloidal suspension of 99mTc-Fe2O3 by aThis study was supported by the following grants: CFF RDP R026, NIH SCOR 5-P50- spinning disk aerosol generator to produce dry iron oxide particles (16).
HL60280–05, and GCRC RR00046.
Correspondence and requests for reprints should be addressed to Namita Sood, Protocol
M.D., Division of Pulmonary and Critical Care Medicine, Ohio State University,
Subjects were studied over 4 days in a randomized, double-blind, cross-201, Heart & Lung Research Institute, 473 West 12th Avenue, Columbus, OH
over design. To limit isotope exposure, two groups were studied and43210. E-mail: sood-1@medctr.osu.edu
exposed to a common treatment (0.9% saline). Before isotope wasAm J Respir Crit Care Med Vol 167. pp 158–163, 2003
administered, subjects inhaled solutions of vehicle or amiloride, thenOriginally Published in Press as DOI: 10.1164/rccm.200204-293OC on October 31, 2002
Internet address: www.atsjournals.org different concentrations of saline, for up to 15 minutes (or until
 
Sood, Bennett, Zeman, et al.: Inhaled NaCl and Mucus Clearance 159
TABLE 1. AEROSOLIZED DOSING REGIMENS saline is similar to “basal” (no treatment) clearance in healthy
subjects, and does not represent a stimulated rate of MCC (17,Group 1* (n  7) Group 2† (n  9)
18). In general, the whole lung (Figure 2) and peripheral lung
0.12% saline/0.12% saline ND (data not shown) MCC curves revealed an early period of rapid
Amiloride/0.12% saline ND clearance, which then plateaued to a slower rate. This change
0.12% saline/0.9% saline 0.12% saline/0.9% saline in rate could reflect either a true slowing of clearance, and/orAmiloride/0.9% saline Amiloride/0.9% saline
reduced availability of clearable isotopic marker in conductingND 0.12% saline/7% saline
airways, over time.ND Amiloride/7% saline
To quantitate the initial rate of rapid isotope clearance, we
Definition of abbreviation: ND  not done. calculated the breakpoint in the rate of clearance, which reflects
Aerosolized dosing regimens were administered in randomized and blinded the time-shift from a phase of rapid to apparent “slower” clear-
fashion on four separate days to two groups of study subjects.
ance (see Methods). The breakpoint in the rate of whole and*C/P  1.40  0.08.
peripheral lung MCC for all study days was determined to be†C/P  1.51  0.06.
20 minutes. This analysis indicated that the predominant effect
of the different aerosolized solutions on rates of MCC occurred
within the first 20 minutes after deposition of isotope-labeled
“sputter”; see Figure 1), using a PARI LC Star nebulizer with an iron oxide particles.
MMAD of approximately 4 m (Figure 1). The lowest concentration The whole lung clearance rates (%/minute) as a function
of saline (0.12%; hypotonic) was selected because the rate of MCC is of concentration of inhaled saline with or without amiloride
not stimulated in normal subjects after inhalation of 0.12% saline, i.e., pretreatment over the first 20 minutes for subjects from both
the rate of MCC after hypotonic saline (alone) is the “basal” rate of groups are summarized in Figure 2C. For inhaled saline withoutMCC in healthy subjects (17, 18). Subsequently, subjects inhaled an
amiloride pretreatment, increasing “masses” of NaCl, deliveredaerosol (4 m MMAD; geometric SD  1.25) of insoluble 99mTc-Fe2O3
by aerosols with varying concentrations of NaCl, increased the(19, 20). An initial deposition scan was recorded and  scanning was
rate of MCC when tested for all study subjects (p  0.04, analysisperformed for 120 minutes (2-minute images every 10 minutes) to
of variance). There was little effect for 0.9% saline to increasemeasure particle clearance. Subjects returned at 24 hours after deposi-
tion for a 30 minute scan. MCC as compared with 0.12% saline (p  0.19, nonpaired t test),
whereas 7% saline clearly increased MCC as compared with
Data Analysis 0.12 saline (p  0.03). Pretreatment with amiloride increased
The approach for measurement and analysis is well-used in our labs the rates of MCC observed after inhalation of 0.12% (p  0.02)
(17, 21). In brief, particle clearance after inhalation is initially rapid, but or 0.9% saline (p  0.0001), but not 7% saline. Further, with
slows after the first 10–30 minutes (Figure 2). This pattern of clearance amiloride pretreatment, the rates of MCC after inhalation of
(initially rapid, with later slowing) is also seen in measures of “baseline” 0.12 and 0.9% saline (i.e., 1.1–1.3%/minute) were similar to that(no treatment) MCC (22). Initial comparisons between different aerosol
observed for 7% saline alone.treatments were made by repeated-measures analysis of variance of
The peripheral lung clearance rates (%/minute) over the firstclearance over the initial 20 minutes for each day. Comparisons between
20 minutes for all subjects are shown in Figure 2D. For inhaleddoses of saline (0.12% versus 0.9% saline) were assessed by nonpaired
t tests, whereas comparisons of pretreatment with amiloride were as- saline aerosols without amiloride pretreatment, there was a ten-
sessed by two-tailed paired t tests. Significance was set at p  0.05 for dency for increasing “masses” of inhaled NaCl, i.e., increased
two-tailed analysis. Unless otherwise specified, data are presented as concentrations of saline, to increase the rate of MCC (p  0.12,
means  SD. analysis of variance). Comparisons of MCC after inhalation of
different concentrations of saline revealed no effect of 0.9%Modeling (Estimating) the Relative Volume (Depth) of ASL
saline to increase MCC as compared with 0.12% saline, but 7%after Aerosolized Saline
saline increased peripheral MCC compared with 0.12% saline.
These estimates used a model that has been validated by comparison Again, pretreatment with amiloride increased peripheral MCC
with experimental (total and regional deposition) lung deposition mea- rates after inhalation of 0.12 and 0.9% saline (p  0.05), butsurements in humans over a large range of particle sizes (23–26).
not 7% saline. After pretreatment with amiloride, the rates of
MCC (approximately 1%/minute) were similar for all concentra-RESULTS tions of inhaled saline.
We also analyzed the MCC data over longer-term intervalsWhole lung clearances of 99mTc iron oxide particles are shown
(0 to 60 and 120 minutes). For whole lung clearance, pretreat-for different aerosolized solutions in the first group (n  7;
ment with inhaled amiloride systematically increased the fractionFigure 2A) and the second group (n  9; Figure 2B) of subjects.
The pattern and rate of clearance after inhalation of 0.12/0.12% of isotope cleared after inhalation of 0.12% saline (p  0.001
Figure 1. Design of protocol
for each study day. After back-
ground lung scan, subjects in-
haled vehicle (0.12% saline) or
amiloride (10 mM in a nebu-
lizer), followed by different
doses of NaCl. Isotope (Tc99m-
labeled Fe2O3 particles) was
then inhaled as a radio-marker
for measurement of mucocili-
ary clearance over 2 hours, with
a follow-up scan 24 hrs later.
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Figure 2. Mucociliary clearance (retention versus time) for different aerosolized solutions. A shows whole lung clearance for the first group of
subjects (n  7; C/P 1.40  0.08), and B shows whole lung clearance for the second group of subjects (n  9; C/P 1.51  0.06); amiloride
pretreatment increased the rates of whole lung mucociliary clearance for 0.12 and 0.9% saline over 2 hours (p  0.001), but did not enhance
the effects of 7% saline (see text for details). C shows whole lung mucociliary clearance rates over the initial 20 minutes for different treatment
regimens for all subjects. Increasing doses of saline (0.12 to 0.9 to 7%) increased the rates of MCC (p  0.04; analysis of variance). Pretreatment
with amiloride increased rates of whole lung MCC for 0.12 and 0.9% saline (*p  0.02 compared with 0.12% alone; ‡p  0.0001, compared
with 0.9% alone), but not 7% saline. D shows peripheral lung mucociliary clearance rates over the initial 20 minutes for different treatment
regimens for all subjects. Increasing doses of saline (0.12 to 0.9 to 7%) tended to increase the rates of peripheral MCC (p  0.l2; analysis of
variance). Pretreatment with amiloride increased rates of peripheral lung MCC for 0.12 and 0.9% saline (*p  0.02 compared with 0.12% alone;
†p  0.05 compared with 0.9% alone), but not 7% saline.
for 60 and 120 minutes) and 0.9% saline (p  0.004 for 120 The aerosol inhalations were well tolerated by all subjects,
and there were no episodes of bronchospasm or other untowardminutes), when compared with pretreatment with inhalation of
vehicle (Figure 2A). In contrast, amiloride pretreatment did effects. To assess the effect of study design on the results, we
determined the role of several covariates to any observed differ-not increase the “net clearance” induced by 7% saline when
compared with pretreatment with vehicle (Figure 2B). Similar ences in clearance for the different treatment study days. Overall,
only subject and treatment were significant (p  0.05) predictorspatterns were seen for net clearance over 60 and 120 minutes
from the peripheral lung regions (data not shown). of the variation in 20-minute clearance rate. For 0.9 and 7%
saline, treatment interaction with C/P ratio was significant (p At 24 hours (Figures 2A and 2B), pretreatment with amiloride
tended to increase net clearance when compared with 0.12 and 0.03) for predicting 20-minute clearance rate, which implies that
the difference in 20-minute clearance rate between treatments0.9% saline, alone (p  0.09 for whole lung; p  0.001 for
peripheral lung), but amiloride had no effect on net clearance was greatest as C/P increased. There was no evidence for a role
for cough frequency over the period of interest, treatment order, oras compared with 7% saline aerosols with vehicle pretreatment
for either whole or peripheral lung. interactions between these two variables and treatment (p  0.4).
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ing estimates may be better correlated with conditions after
pretreatment with amiloride, which blocks Na (and volume)
absorption.
DISCUSSION
This study demonstrated that maneuvers designed to acutely
increase the volume (depth) of ASL are associated with in-
creased rates of MCC in normal subjects (Figure 2). In general,
increasing the amount (mass) of salt deposited on airway surfaces
by increasing the concentration of NaCl in aerosols increased
MCC. Similarly, pretreatment with amiloride to promote reten-
tion of inhaled NaCl on airway surfaces increased the effect of
saline aerosols to raise MCC rates.
We designed our protocols to focus on the effects of added
salt on ciliary-dependent, rather than cough-dependent, Fe2O3
(mucus) clearance. To remove the potential contribution of
cough clearance in response to the different saline  amiloride
aerosol solutions, subjects were exposed to the different aerosol
solutions before radiolabeled isotopic marker was given. With
this protocol, there were no significant episodes of coughing
after the inhalation of the tracer. Only four subjects experienced
any cough and a multivariate analysis failed to show any effect
of cough on MCC. There also appeared to be no change in
airway caliber after delivery of the test aerosol that would bias
estimation of MCC based on tracer deposition, as a comparable
deposition of the inhaled radiolabel was achieved over the four
study days as reflected by relatively uniform C/P ratios. Thus,
there were no artifacts of cough-clearance or regional differences
in tracer deposition inherent in this protocol design, which may
Figure 3. Changes in depth of airway surface liquid (ASL) after inhala- have limited quantitative interpretation of the effects of saline
tion of saline, as estimated by modeling techniques (see METHODS). A aerosols on MCC in other studies, where cough occurred during
shows the increase in depth of ASL (left ordinate) after inhalation of nebulization of (hypertonic) saline or amiloride (11, 12).
0.9% saline versus the fraction of aerosol particles deposited (right In this study, there was little effect of inhaled isotonic (0.9%)
ordinate) on the surfaces of proximal to distal generations of conducting saline to stimulate MCC as compared with a hypotonic saline
airways (abscissa). B shows the predicted increase in depth of ASL after
(0.12). This result may reflect the fact that the difference ininhalation of 0.12 and 0.9 and 7% saline.
inhaled salt mass between a 0.12% saline aerosol (1.2 mg) and
a 0.9% saline aerosol (9 mg) is relatively small (approximately
8 mg). In contrast, the mass of delivered salt is relatively large
with 7% saline (70 mg), perhaps accounting for the large increaseTo approximate the relative change in depth of ASL along
in MCC after inhalation of 7% as compared with 0.12 and 0.9%the tracheobronchial tree, we estimated the increase in the depth
saline. Indeed, this hypothesis is consistent with the model analy-of ASL after acute inhalation of saline from modeling (see Meth-
ses comparing salt deposition with increased ASL height (Fig-ods). In Figure 3A, we plotted estimates of particle deposition
ure 3B).fraction after inhalation of 0.9% saline (right ordinate) based on
Interestingly, amiloride administered before inhalation ofthe parameters of the aerosol droplet size and respiratory flow
smaller doses of saline (0.12 or 0.9%) induced twofold increasesrates. We then estimated the volume of ASL “added” from
in rates of MCC over the comparable saline doses with vehiclethe volume of 0.9% saline aerosol deposited and the estimated
pretreatment for whole and peripheral lung (see Figures 2C andsurface area of each airway generation (left ordinate). Although
2D). The effect of amiloride pretreatment to increase the MCCthe deposition fraction of particles is relatively similar along
response to 0.12 and 0.9% saline (Figure 2) could reflect thedifferent generations of the conducting airways, the model sug-
capacity of amiloride to conserve all salt added to airway surfacesgests that the greatest relative increase in the depth of ASL
before and during the interval of the MCC measurement. How-occurs in proximal (third generation) bronchi, whereas the small-
ever, because the quantity of added salt with 0.12% saline isest change is in more distal (12th–16th generation) bronchioles.
relatively small, and there is little predicted effect on ASL heightThese differences in estimated depth of ASL added largely re-
(Figure 3), the increase in MCC rates effected by amiloride mayflect the relative surface areas of proximal (small surface) versus
reflect the drug’s effect to block basal ASL volume absorptiondistal (large surface) conducting airways. In Figure 3B, we plot-
(4, 27). The failure of amiloride to potentiate the effect of 7%ted the relative estimated change in added ASL depth as a
saline inhalation on MCC could reflect the fact that the blockfunction of the concentration of inhaled saline. As can be seen,
of basal absorption is small relative to the very large mass ofthe change in ASL depth is not a function of the fold-change
salt, and consequently, ASL volume, which is added to the airwayin saline concentration (i.e., eightfold for 0.9 versus 0.12%, and
surface by the concentrated (7%) salt solution. It is also likely7 versus 0.9%, respectively), but rather a direct function of the
that the addition of such a large mass of salt led to an acutemass of NaCl added to the airway surface by the aerosols of
increase in the ASL, resulting in a clearance of most of thedifferent concentrations of NaCl (see Figure 3B). We recognize
radioisotope by 20 minutes.that saline is deposited over 15 minutes in our research protocol
From the MCC protocol used in this study, it is difficult toin humans, and absorption of Na (and volume) is taking place
over that interval, in the absence of amiloride. Thus, these model- clearly define the duration of the effect on MCC after acute
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addition of salt  amiloride to airway surfaces (Figure 2). The the normal subjects in the study led to ASL volume addition
with selective hydration/swelling of the mucus layer and an accel-effect of inhaled saline to rapidly accelerate MCC appeared to
last only 20 minutes, which (if true) could reflect rapid absorption eration of MCC rates, although the precise mechanism to link
these events is not known. The greater change in rates of MCCof Na (and volume) and a short duration of effect on MCC. This
interpretation is compatible with studies of well-differentiated in whole lung versus peripheral regions after similar aerosol
treatments (Figures 2C and 2D), which parallel the predictedhuman bronchial epithelial cell cultures that observed rapid
( 12 min) absorption of an equivalent quantity of saline (9%) regional changes in ASL volume (Figure 3B), are also congruent
with this hypothesis.(9, 15). However, the strategy to pretreat with amiloride and
to block volume absorption would be predicted to extend the In summary, maneuvers that are predicted to acutely increase
the volume of ASL are associated with acceleration of MCC ratesduration of effect at least 30 to 60 minutes beyond the 20 minutes
observed here, as demonstrated previously in vitro (9). Interest- in normal subjects. These findings are consistent with previous
ingly, in vivo measurements in patients with PHA also demon- studies that demonstrated the short-term effect of inhaled hyper-
strated that the duration of rapid radiotracer clearance, i.e., tonic saline and/or amiloride to increase mucociliary clearance
“MCC,” lasted only 20 minutes (14). Because patients with PHA in patients with cystic fibrosis (4, 11, 12, 28, 29). The development
have a genetic loss-of-function defect of Na channels with a of long-acting osmotic agents, and/or drugs that block volume
constitutive defect in volume absorption, the duration (20 min- absorption (or stimulate liquid secretion) in the airways, has
utes) of rapid rate of particle clearance (MCC) in these patients therapeutic potential for the treatment of patients with reduced
cannot reflect the variables in this study (i.e., retention time of volume of ASL, including cystic fibrosis.
salt or amiloride on airway surfaces), but likely reflects a techni-
Acknowledgment : The authors express their appreciation to Lisa Brown for graph-cal limitation of the MCC protocol. The simplest hypothesis is ical and editorial assistance.
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